Hematopoietic-Derived Galectin-3 Causes Cellular and Systemic Insulin Resistance

Cell

Volumn 167, Issue 4, 2016, Pages 973-984.e12

  Li, Pingping ^a,b,c   Liu, Shuainan ^a,b   Lu, Min ^c,d   Bandyopadhyay, Gautum ^c   Oh, Dayoung ^c   Imamura, Takeshi ^e   Johnson, Andrew M F ^c   Sears, Dorothy ^c   Shen, Zhufang ^a,b   Cui, Bing ^a,b   Kong, Lijuan ^a,b   Hou, Shaocong ^a,b   Liang, Xiao ^a,b   Iovino, Salvatore ^d   Watkins, Steven M ^f   Ying, Wei ^c   Osborn, Olivia ^c   Wollam, Joshua ^c   Brenner, Martin ^d   Olefsky, Jerrold M ^c  

^a INSTITUTE OF MATERIA MEDICA   (China)

^b PEKING UNION MEDICAL COLLEGE   (China)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d MERCK RESEARCH LABORATORIES   (United States)

^e SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^f Lipomics Technologies   (United States)

Author keywords

galectin 3; inflammation; insulin resistance

Indexed keywords

GALECTIN 3; GLUCOSE; INSULIN; INSULIN RECEPTOR;

ADIPOCYTE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHEMOTAXIS; CLINICAL ARTICLE; CONTROLLED STUDY; GLUCOSE INTOLERANCE; GLUCOSE TRANSPORT; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; INFLAMMATION; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIVER CELL; MACROPHAGE MIGRATION; MALE; MOUSE; MUSCLE CELL; NONHUMAN; OBESITY; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; ANIMAL; ANTAGONISTS AND INHIBITORS; BLOOD; DIABETES MELLITUS, TYPE 2; GENETICS; IMMUNOLOGY; KNOCKOUT MOUSE; MACROPHAGE; METABOLISM; PATHOLOGY;

ADIPOCYTES; ANIMALS; CHEMOTAXIS; DIABETES MELLITUS, TYPE 2; GALECTIN 3; HEPATOCYTES; HUMANS; INSULIN; INSULIN RESISTANCE; MACROPHAGES; MICE; MICE, KNOCKOUT; MUSCLE CELLS; OBESITY;

EID: 84995554134     PISSN: 00928674     EISSN: 10974172     Source Type: Journal    
DOI: 10.1016/j.cell.2016.10.025     Document Type: Article

References (52)

1. Ahmad, N., Gabius, H.J., André, S., Kaltner, H., Sabesan, S., Roy, R., Liu, B., Macaluso, F., Brewer, C.F., Galectin-3 precipitates as a pentamer with synthetic multivalent carbohydrates and forms heterogeneous cross-linked complexes. J. Biol. Chem. 279 (2004), 10841–10847.
2. Baek, J.H., Kim, S.J., Kang, H.G., Lee, H.W., Kim, J.H., Hwang, K.A., Song, J., Chun, K.H., Galectin-3 activates PPARγ and supports white adipose tissue formation and high-fat diet-induced obesity. Endocrinology 156 (2015), 147–156.
3. Barondes, S.H., Castronovo, V., Cooper, D.N., Cummings, R.D., Drickamer, K., Feizi, T., Gitt, M.A., Hirabayashi, J., Hughes, C., Kasai, K., et al. Galectins: a family of animal beta-galactoside-binding lectins. Cell 76 (1994), 597–598.
4. Barondes, S.H., Cooper, D.N., Gitt, M.A., Leffler, H., Galectins. Structure and function of a large family of animal lectins. J. Biol. Chem. 269 (1994), 20807–20810.
5. Birkenfeld, A.L., Shulman, G.I., Non alcoholic fatty liver disease, hepatic insulin resistance and type 2 diabetes. Hepatology 59 (2014), 713–723.
6. Darrow, A.L., Shohet, R.V., Galectin-3 deficiency exacerbates hyperglycemia and the endothelial response to diabetes. Cardiovasc. Diabetol., 14, 2015, 73.
7. Donath, M.Y., Dalmas, É., Sauter, N.S., Böni-Schnetzler, M., Inflammation in obesity and diabetes: islet dysfunction and therapeutic opportunity. Cell Metab. 17 (2013), 860–872.
8. Feng, B., Jiao, P., Nie, Y., Kim, T., Jun, D., van Rooijen, N., Yang, Z., Xu, H., Clodronate liposomes improve metabolic profile and reduce visceral adipose macrophage content in diet-induced obese mice. PLoS ONE, 6, 2011, e24358.
9. Gao, P., Simpson, J.L., Zhang, J., Gibson, P.G., Galectin-3: its role in asthma and potential as an anti-inflammatory target. Respir. Res., 14, 2013, 136.
10. Haffner, S., Taegtmeyer, H., Epidemic obesity and the metabolic syndrome. Circulation 108 (2003), 1541–1545.
11. He, W., Barak, Y., Hevener, A., Olson, P., Liao, D., Le, J., Nelson, M., Ong, E., Olefsky, J.M., Evans, R.M., Adipose-specific peroxisome proliferator-activated receptor gamma knockout causes insulin resistance in fat and liver but not in muscle. Proc. Natl. Acad. Sci. USA 100 (2003), 15712–15717.
12. Hotamisligil, G.S., Peraldi, P., Budavari, A., Ellis, R., White, M.F., Spiegelman, B.M., IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance. Science 271 (1996), 665–668.
13. Huang, J., Imamura, T., Babendure, J.L., Lu, J.C., Olefsky, J.M., Disruption of microtubules ablates the specificity of insulin signaling to GLUT4 translocation in 3T3-L1 adipocytes. J. Biol. Chem. 280 (2005), 42300–42306.
14. Iacobini, C., Menini, S., Ricci, C., Scipioni, A., Sansoni, V., Cordone, S., Taurino, M., Serino, M., Marano, G., Federici, M., et al. Accelerated lipid-induced atherogenesis in galectin-3-deficient mice: role of lipoxidation via receptor-mediated mechanisms. Arterioscler. Thromb. Vasc. Biol. 29 (2009), 831–836.
15. Iacobini, C., Menini, S., Ricci, C., Blasetti Fantauzzi, C., Scipioni, A., Salvi, L., Cordone, S., Delucchi, F., Serino, M., Federici, M., et al. Galectin-3 ablation protects mice from diet-induced NASH: a major scavenging role for galectin-3 in liver. J. Hepatol. 54 (2011), 975–983.
16. Imamura, T., Vollenweider, P., Egawa, K., Clodi, M., Ishibashi, K., Nakashima, N., Ugi, S., Adams, J.W., Brown, J.H., Olefsky, J.M., G alpha-q/11 protein plays a key role in insulin-induced glucose transport in 3T3-L1 adipocytes. Mol. Cell. Biol. 19 (1999), 6765–6774.
17. Jager, J., Grémeaux, T., Cormont, M., Le Marchand-Brustel, Y., Tanti, J.F., Interleukin-1beta-induced insulin resistance in adipocytes through down-regulation of insulin receptor substrate-1 expression. Endocrinology 148 (2007), 241–251.
18. Joo, H.G., Goedegebuure, P.S., Sadanaga, N., Nagoshi, M., von Bernstorff, W., Eberlein, T.J., Expression and function of galectin-3, a beta-galactoside-binding protein in activated T lymphocytes. J. Leukoc. Biol. 69 (2001), 555–564.
19. Kolterman, O.G., Gray, R.S., Griffin, J., Burstein, P., Insel, J., Scarlett, J.A., Olefsky, J.M., Receptor and postreceptor defects contribute to the insulin resistance in noninsulin-dependent diabetes mellitus. J. Clin. Invest. 68 (1981), 957–969.
20. Lackey, D.E., Olefsky, J.M., Regulation of metabolism by the innate immune system. Nat. Rev. Endocrinol. 12 (2016), 15–28.
21. Lanthier, N., Molendi-Coste, O., Horsmans, Y., van Rooijen, N., Cani, P.D., Leclercq, I.A., Kupffer cell activation is a causal factor for hepatic insulin resistance. Am. J. Physiol. Gastrointest. Liver Physiol. 298 (2010), G107–G116.
22. Larsen, C.M., Faulenbach, M., Vaag, A., Vølund, A., Ehses, J.A., Seifert, B., Mandrup-Poulsen, T., Donath, M.Y., Interleukin-1-receptor antagonist in type 2 diabetes mellitus. N. Engl. J. Med. 356 (2007), 1517–1526.
23. Lee, Y.S., Kim, J.W., Osborne, O., Oh, D.Y., Sasik, R., Schenk, S., Chen, A., Chung, H., Murphy, A., Watkins, S.M., et al. Increased adipocyte O2 consumption triggers HIF-1α, causing inflammation and insulin resistance in obesity. Cell 157 (2014), 1339–1352.
24. Li, P., Lu, M., Nguyen, M.T., Bae, E.J., Chapman, J., Feng, D., Hawkins, M., Pessin, J.E., Sears, D.D., Nguyen, A.K., et al. Functional heterogeneity of CD11c-positive adipose tissue macrophages in diet-induced obese mice. J. Biol. Chem. 285 (2010), 15333–15345.
25. Li, P., Spann, N.J., Kaikkonen, M.U., Lu, M., Oh, D.Y., Fox, J.N., Bandyopadhyay, G., Talukdar, S., Xu, J., Lagakos, W.S., et al. NCoR repression of LXRs restricts macrophage biosynthesis of insulin-sensitizing omega 3 fatty acids. Cell 155 (2013), 200–214.
26. Li, L.C., Li, J., Gao, J., Functions of galectin-3 and its role in fibrotic diseases. J. Pharmacol. Exp. Ther. 351 (2014), 336–343.
27. Li, P., Oh, D.Y., Bandyopadhyay, G., Lagakos, W.S., Talukdar, S., Osborn, O., Johnson, A., Chung, H., Mayoral, R., Maris, M., et al. LTB4 promotes insulin resistance in obese mice by acting on macrophages, hepatocytes and myocytes. Nat. Med. 21 (2015), 239–247.
28. Liu, F.T., Rabinovich, G.A., Galectins: regulators of acute and chronic inflammation. Ann. N Y Acad. Sci. 1183 (2010), 158–182.
29. Liu, F.T., Hsu, D.K., Zuberi, R.I., Kuwabara, I., Chi, E.Y., Henderson, W.R. Jr., Expression and function of galectin-3, a beta-galactoside-binding lectin, in human monocytes and macrophages. Am. J. Pathol. 147 (1995), 1016–1028.
30. Lu, M., Shyy, J.Y., Sterol regulatory element-binding protein 1 is negatively modulated by PKA phosphorylation. Am. J. Physiol. Cell Physiol. 290 (2006), C1477–C1486.
31. Lu, M., Li, P., Pferdekamper, J., Fan, W., Saberi, M., Schenk, S., Olefsky, J.M., Inducible nitric oxide synthase deficiency in myeloid cells does not prevent diet-induced insulin resistance. Mol. Endocrinol. 24 (2010), 1413–1422.
32. Oh, D.Y., Talukdar, S., Bae, E.J., Imamura, T., Morinaga, H., Fan, W., Li, P., Lu, W.J., Watkins, S.M., Olefsky, J.M., GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects. Cell 142 (2010), 687–698.
33. Olefsky, J.M., Glass, C.K., Macrophages, inflammation, and insulin resistance. Annu. Rev. Physiol. 72 (2010), 219–246.
34. Olefsky, J.M., Kolterman, O.G., Mechanisms of insulin resistance in obesity and noninsulin-dependent (type II) diabetes. Am. J. Med. 70 (1981), 151–168.
35. Pang, J., Rhodes, D.H., Pini, M., Akasheh, R.T., Castellanos, K.J., Cabay, R.J., Cooper, D., Perretti, M., Fantuzzi, G., Increased adiposity, dysregulated glucose metabolism and systemic inflammation in Galectin-3 KO mice. PLoS ONE, 8, 2013, e57915.
36. Patsouris, D., Li, P.P., Thapar, D., Chapman, J., Olefsky, J.M., Neels, J.G., Ablation of CD11c-positive cells normalizes insulin sensitivity in obese insulin resistant animals. Cell Metab. 8 (2008), 301–309.
37. Pejnovic, N.N., Pantic, J.M., Jovanovic, I.P., Radosavljevic, G.D., Milovanovic, M.Z., Nikolic, I.G., Zdravkovic, N.S., Djukic, A.L., Arsenijevic, N.N., Lukic, M.L., Galectin-3 deficiency accelerates high-fat diet-induced obesity and amplifies inflammation in adipose tissue and pancreatic islets. Diabetes 62 (2013), 1932–1944.
38. Pillon, N.J., Bilan, P.J., Fink, L.N., Klip, A., Cross-talk between skeletal muscle and immune cells: muscle-derived mediators and metabolic implications. Am. J. Physiol. Endocrinol. Metab. 304 (2013), E453–E465.
39. Reaven, G.M., The insulin resistance syndrome: definition and dietary approaches to treatment. Annu. Rev. Nutr. 25 (2005), 391–406.
40. Salameh, B.A., Cumpstey, I., Sundin, A., Leffler, H., Nilsson, U.J., 1H-1,2,3-triazol-1-yl thiodigalactoside derivatives as high affinity galectin-3 inhibitors. Bioorg. Med. Chem. 18 (2010), 5367–5378.
41. Samuel, V.T., Liu, Z.X., Qu, X., Elder, B.D., Bilz, S., Befroy, D., Romanelli, A.J., Shulman, G.I., Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease. J. Biol. Chem. 279 (2004), 32345–32353.
42. Sano, H., Hsu, D.K., Yu, L., Apgar, J.R., Kuwabara, I., Yamanaka, T., Hirashima, M., Liu, F.T., Human galectin-3 is a novel chemoattractant for monocytes and macrophages. J. Immunol. 165 (2000), 2156–2164.
43. Sato, S., Hughes, R.C., Regulation of secretion and surface expression of Mac-2, a galactoside-binding protein of macrophages. J. Biol. Chem. 269 (1994), 4424–4430.
44. Sato, S., Ouellet, N., Pelletier, I., Simard, M., Rancourt, A., Bergeron, M.G., Role of galectin-3 as an adhesion molecule for neutrophil extravasation during streptococcal pneumonia. J. Immunol. 168 (2002), 1813–1822.
45. Sears, D.D., Hsiao, G., Hsiao, A., Yu, J.G., Courtney, C.H., Ofrecio, J.M., Chapman, J., Subramaniam, S., Mechanisms of human insulin resistance and thiazolidinedione-mediated insulin sensitization. Proc. Natl. Acad. Sci. USA 106 (2009), 18745–18750.
46. Stanley, T.L., Zanni, M.V., Johnsen, S., Rasheed, S., Makimura, H., Lee, H., Khor, V.K., Ahima, R.S., Grinspoon, S.K., TNF-alpha antagonism with etanercept decreases glucose and increases the proportion of high molecular weight adiponectin in obese subjects with features of the metabolic syndrome. J. Clin. Endocrinol. Metab. 96 (2011), E146–E150.
47. Steele, R., Influences of glucose loading and of injected insulin on hepatic glucose output. Ann. N Y Acad. Sci. 82 (1959), 420–430.
48. Vollenweider, P., Martin, S.S., Haruta, T., Morris, A.J., Nelson, J.G., Cormont, M., Le Marchand-Brustel, Y., Rose, D.W., Olefsky, J.M., The small guanosine triphosphate-binding protein Rab4 is involved in insulin-induced GLUT4 translocation and actin filament rearrangement in 3T3-L1 cells. Endocrinology 138 (1997), 4941–4949.
49. Weisberg, S.P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R.L., Ferrante, A.W. Jr., Obesity is associated with macrophage accumulation in adipose tissue. J. Clin. Invest. 112 (2003), 1796–1808.
50. Xu, H., Barnes, G.T., Yang, Q., Tan, G., Yang, D., Chou, C.J., Sole, J., Nichols, A., Ross, J.S., Tartaglia, L.A., Chen, H., Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J. Clin. Invest. 112 (2003), 1821–1830.
51. Yang, R.Y., Rabinovich, G.A., Liu, F.T., Galectins: structure, function and therapeutic potential. Expert Rev. Mol. Med., 10, 2008, e17.
52. Zhong, L., Ding, Y., Bandyopadhyay, G., Waaler, J., Börgeson, E., Smith, S., Zhang, M., Phillips, S.A., Mahooti, S., Mahata, S.K., et al. The PARsylation activity of tankyrase in adipose tissue modulates systemic glucose metabolism in mice. Diabetologia 59 (2016), 582–591.